Wall Street major averages posted weekly loses amid an AI-tech trade that continued to struggle, with lower consumer ...
Pfizer on Thursday closed its up to $10 billion acquisition of Metsera after winning shareholder approval, gaining a foothold ...
CEO and chairman Albert Bourla told Yahoo Finance Executive Editor Brian Sozzi during Yahoo Finance's annual Invest conference that the $10 billion acquisition of GLP-1 maker Metsera (MTSR) is part of ...
MRNA is likely to have faced earnings pressure and pipeline setbacks as waning COVID-19 vaccine demand weighs on its outlook.
Moderna lowered the top end of its 2025 revenue forecast by $200 million on Thursday, citing weaker-than-expected sales of ...
Pfizer, BioNTech request EU conditional approval Regulator says panel to meet Dec 29 at latest Rival Moderna also submits EU filing for its shot Both groups have applied for U.S. emergency use ...
The fall COVID-19 vaccine season is starting slowly for Pfizer, with U.S. sales of its Comirnaty shots sinking 25% after ...
The fall COVID-19 vaccine season is starting slowly for Pfizer, with U.S. sales of its Comirnaty shots sinking 25% after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results